1.Treatment of Uncomplicated Male Gonococcal Urethritis with Rosoxacin.
Korean Journal of Dermatology 1986;24(3):358-363
Between September to October 1985, 61 male patients with uncomplicated genital gonorrhea, including 33 PPNG urethritis, were treated with single oral dose of rosoxaci, a new oral quinolone derivative, 300 mg Fifty-three patients returned for a test of cure 3 5 days after the treatment. When a patient was found to be not cured, a second course of treatment was given and followed as above. The overall failure rate of initial treatment was 11.3%(6/53). It was 15. 2%(5/33) for PPNG urethritis and 5%(1/20) for non-PPNG urethritis. During the course of this trial the rate af PPNG among pretreatment isolates was exceptionally high(62.2g) compared to 277. during the period of 198l~4. If the PPNG prevalance rate had been a little lower, for instance 30g the overall failure rate would have been much lower(4.9%). When the second treatment was given to the failure cases 4-6 days after the first treatment. The overall failure rate dropped to 3.8%, 3.1% for PPNG urethritis and 5.0% for non-PPNG urethritis. Ten patients (2l, 3p,) developed postgoriococcal urethritie. Susceptibility test, with disks containing rosoxacin 5mcg, showed the inhibition zone to be greater than 34mm. Eight patients developed minor side effects: dizziness or gastritis. The rosoxacin, oral dose of 300 mg, regimen gave the best result yet by oral treatment for gonorrheae in recent years in Korea.
Dizziness
;
Gastritis
;
Gonorrhea
;
Humans
;
Korea
;
Male*
;
Urethritis*
2.A study of low dose purified follicle-stimulating hormone supplemented with gonadotropin releasing hormone agonist in women with polycystic ovarian disease.
Eui Jong HUR ; Sang Hoon LEE ; Do Hwan BAE
Korean Journal of Obstetrics and Gynecology 1992;35(11):1597-1604
No abstract available.
Female
;
Follicle Stimulating Hormone*
;
Gonadotropin-Releasing Hormone*
;
Gonadotropins*
;
Humans
;
Ovarian Diseases*
3.The treatment of unruptured tubal pregnancy with intra-amniotic methotrexate injection under transcaginal sono-guidance.
Eui Jong HUR ; Sang Hoon LEE ; Do Hwan BAE
Korean Journal of Obstetrics and Gynecology 1992;35(1):17-23
No abstract available.
Female
;
Methotrexate*
;
Pregnancy
;
Pregnancy, Tubal*
4.A study of endogenous gonadotropin suppression with oral contraceptives and triggering follicular maturation with GnRH-a before in vitro fertilization.
Sang Hoon LEE ; Eui Jong HUR ; Do Hwan BAE
Korean Journal of Obstetrics and Gynecology 1993;36(7):938-946
No abstract available.
Contraceptives, Oral*
;
Fertilization in Vitro*
;
Gonadotropins*
5.A Case of Benign Lichenoid Keratosis.
Hoon HUR ; Chang Woo LEE ; Joong Hwan KIM
Korean Journal of Dermatology 1987;25(2):260-263
A case of benign lichenoid keratosis(BLK) developed in a 25-year-old female is presented. She had two erythematous plaques with slightly verrucous surfaces on the lips for 4 weeks. A biopsy specirnen taken from the periphery of the lesion revealed a focal parakeratosis, the absence of granular cells, and hydropic degeneration of the basal cells in the epidermis. The upper dermal infiltrate composed chiefly of lymphacytes intermingled with a few histiocytes was also seen. The direct immunofluorescent study showed depositions of a few cytoid bodies and fibrin around the areas of the dermoepidermal junction. These plaques on her lips, demonstrating lichenoid tissue changes, cleared in 8 weeks from the evalution, without any treatment.
Adult
;
Biopsy
;
Epidermis
;
Female
;
Fibrin
;
Histiocytes
;
Humans
;
Keratosis*
;
Lip
;
Parakeratosis
6.The Effects of Psychosocial Interventions to Improve Stress and Coping in Patients with Breast Cancer.
Cho Ja KIM ; Hea Kung HUR ; Duck Hee KANG ; Bo Hwan KIM
Journal of Korean Academy of Nursing 2006;36(1):169-178
PURPOSE: The purpose of this study was to examine stress, coping, and immune response effects of a psychosocial intervention program based on the PNI model and Stress-Appraisal-Coping for Korean patients with breast cancer. METHODS: A nonequivalent control group pretest-posttest design was used. The participants who had survived breast cancer and lived in Wonju city and the surrounding area were assigned to an intervention group (N=21) or a control group(N=18).We conducted a 12-week intervention, 2 hours a day weekly, and measured the variables at baseline, six and twelve weeks later. Dependent variables are: stress, anxiety-depression and anger, and immune response. RESULTS: Patients in the psychosocial intervention program reported significantly less stress perception (U=31.500, p=.023), more problem solving ability and less problem avoidance in coping (U=20.500, p= .013; U=29.500, p=.040), and less anxiety-depression (U=22.000, p=.023). No difference, however, was found in anger and immune responses between the two groups. Intervention effects were evident at week 6 and 12 for anxiety-depression, and at week 6 for problem avoidance in coping, the same time that NK cell counts and the T8 decreased. CONCLUSIONS: These results suggested positive effects of a psychosocial intervention program. However, the results are inconclusive due to the small sample.
Stress, Psychological/etiology/*therapy
;
*Social Support
;
Middle Aged
;
Humans
;
Female
;
Breast Neoplasms/*psychology
;
Adult
;
*Adaptation, Psychological
7.Treatment of Recalcitrant Rosacea with 13 - Cis - Retinoic Acid.
Hoon HUR ; Kyu Uang WHANG ; Chang Woo LEE ; Jae Hong KIM ; Joong Hwan KIM
Korean Journal of Dermatology 1986;24(2):238-241
Eight men with a one-ta-seven-year history of rosacea which poorly controlled by oral tetracycline or metronidazole, with or without topical medications, were given 13-cis-retinoic acid in dosages of p.5 to 0. 7 mg/kg/day for eight weeks. The size of erytherna and the number of papules had been gradually decreased since the second week of treatment. Eight weeks later more than 75p, regression was recognized in six patients, however telangiectasia remained unchanged. All eight patients complained of only mild degrees of cheilitis and dryness of the nose, and had no evidence of the serologic abnormalities on the tests examined during the period of therapy.
Cheilitis
;
Humans
;
Isotretinoin
;
Male
;
Metronidazole
;
Nose
;
Rosacea*
;
Telangiectasis
;
Tetracycline
;
Tretinoin*
8.A STUDY THE SHADE CHANGE OF SEVERAL KINDS OF ALL CERAMIC CROWNS USED FOR METAL DOWEL CORE.
Sung Il HUR ; Heon Song LIM ; Ju Hwan LIM ; In Ho CHO
The Journal of Korean Academy of Prosthodontics 2001;39(5):477-491
The purpose of this study is to compared and analyze the shade changes(deltaE)about In-Ceram(R),IPS-Empress(R),OPC(R) by using of the spectrophotometer arising from initial status and before and after cementation of the resin cement mounted on the metal core. We used a couple of statistics such as 'One-Way ANOVA'and Multiple Range Test. We could be able to verify significantly what is being discussed here up to 95%. The results drawn from our research are as follows: 1. At the time of our experiments regarding the initial shapes of all-ceramic and mounting status of all-ceramic on the metal crown(deltaE1), and a comparison of mounting of all ceramic on the metal crown with all-ceramic cemented on the metal core(deltaE2), at the time of shade change of initial shapes and after we cemented on the metal core. (1) no significant difference among all-ceramics was found. (2) no particular difference was found regarding the In-Ceram(R) (3) a significant difference between the deltaE1 and deltaE2 regarding the IPSS-Empress(R) was found (P<0.05). (4) a significant difference between the deltaE1 and deltaE2 regarding the OPC? was found (P<0.05). 2. When we compared the shade changes (deltaE) resulted from before and after the cementation on each of the parts involved of some all-ceramic . we could be able to find shape change increase from incisal third, middle third, and cervical third in that order in In-Cream(R)(spinell), IPS Empress(R) and OPC(R) all. In addition , we could be able to find a siginificant difference between cervical third and incisal third, middle third. (P<0.05) From what we have just seen, we might conclude that there is a significant shade change difference before and after the cementation with respect to IPS-Empress(R)and OPC(R). In addition, we could also be able to find more shade change difference at the cervical third rather than incisal third and middle third depending on the parts involved.
Cementation
;
Ceramics*
;
Crowns*
;
Resin Cements
9.Two Cases of Generalized Syringoma.
Hoon HUR ; Kwang Ho CHOI ; Jae Hong KIM ; Joong Hwan KIM
Korean Journal of Dermatology 1985;23(3):399-403
We experienced two cases of generalized syringoma in a 21-year and a 34-year- old healthy woman. A 34-year-old woman have had numerous yellowish to pink papules on the face, anterior chest, upper part of the back and right buttock for the past twelve years. A 21-year-old woman have had numerous yellowish to brownish papules on the face, neck and anterior chest for the past ten years, and her mother had syringoma on the eyelids. Diapnosis was confirmed by clinical and histopathological findings as generalized syringoma.
Adult
;
Buttocks
;
Eyelids
;
Female
;
Humans
;
Mothers
;
Neck
;
Syringoma*
;
Thorax
;
Young Adult
10.Expressions of MAGE-3, PCNA, p21, and p53 Proteins in the Hypopharyngeal Squamous Cell Carcinoma Cell Line (PNUH-12) Analysed by Bivariate Flow Cytometry.
Hee Kyung CHANG ; Deok Jun KIM ; Hwan Jung ROH ; Bang HUR ; Kang Dae LEE ; SPAGNOLI
Korean Journal of Pathology 2000;34(11):901-908
MAGE (melanoma antigen gene) is a tumor specific shared antigen, presented by HLA class I molecules, which is recognized by cytotoxic T lymphocytes. MAGE proteins are expressed in malignant tumor cells, in contrast to no expression in normal or benign tissues except for testis and placenta. MAGE might be a potential target for immunotherapy of malignant tumors. However, its biological aspects associated with cell cycle are not yet described. The flow cytometry is a useful tool for objective and quantitative analyses of heterogenous tumor cell population. To understand the status of MAGE related to cell cycle and its relationship with p53 as the G1 checkpoint regulator, p21, and PCNA as a proliferative index, we investigated expression of MAGE-3 protein, mutant p53, p21, and PCNA by flow cytometry and immunohistochemical stain. In addition, double stains for MAGE-3/p53, p53/PCNA, and p53/p21 were analysed with bivariate flow cytometry. DNA histograms using MAGE-3/PI (DNA) and p53/PI (DNA) were also analysed. The cell line (PNUH- 12) used for this study originated from a hypopharyngeal squamous cell carcinoma, which has point mutation (exon 7, C-->G) of p53. The expression rate of MAGE-3 was 83%, PCNA 85%, and p53 81%. No expression for p21 was identified. MAGE-3 was expressed in cytoplasm, while both PCNA and p53 were expressed in nuclei of tumor cells. With bivariate analyses, coexpression rates of MAGE-3/p53 and p53/PCNA were 0.96 and 0.97, respectively. Both MAGE-3 and p53 showed constantly high level throughout the cell cycle. These results suggest that expression of MAGE-3 and mutant p53 is not dependent on the cell cycle. p21 seems to be inactivated.
Carcinoma, Squamous Cell*
;
Cell Cycle
;
Cell Line*
;
Coloring Agents
;
Cytoplasm
;
DNA
;
Flow Cytometry*
;
Immunotherapy
;
Mutant Proteins
;
Placenta
;
Point Mutation
;
Proliferating Cell Nuclear Antigen*
;
T-Lymphocytes, Cytotoxic
;
Testis